Hypertension

Hypertension is one of the most-claimed conditions at the VA, and almost every veteran who gets the grant lands at 10 percent and stays there. The diastolic numbers required to climb the schedule are so severe that most patients hitting those thresholds are sitting in an ER, not waiting on a rating decision.

That's the puzzle I want to walk through. The rating criteria under 38 CFR § 4.104 Diagnostic Code 7101 technically run from 10 percent to 60 percent, with thresholds tied to diastolic and systolic readings. In practice, the data clusters hard at the bottom. I pulled together the regulatory text, the diagnostic predicate the schedule actually requires, the three service-connection pathways including the Oct 2024 Agent Orange presumptive that's now retroactive, and the documentation patterns that seem to separate stuck 10 percent ratings from the rare cases that move higher. The medical case for service connection is often strong. The path to a meaningful increase is the part that catches most veterans off guard.

TL;DR

• Hypertension is rated under 38 CFR § 4.104 DC 7101 at four tiers: 10, 20, 40, and 60 percent. Diastolic and systolic thresholds determine the tier.
• Diagnosis requires blood pressure readings taken two or more times on at least three different days, per the note to DC 7101. This is a binary evidentiary threshold that some claims fail at the rating stage.
• The 10 percent rating includes a "treated to lower" clause. A history of diastolic pressure predominantly 100 or more, requiring continuous medication, qualifies even if current readings are controlled.
• The Oct 2024 Agent Orange presumptive addition under 38 CFR § 3.309(e), authorized by the PACT Act, opened a retroactive supplemental claim path for Vietnam-era veterans previously denied.
• Most granted hypertension cases land at 10 percent. The 60 percent tier requires diastolic readings predominantly at or above 130, which is hypertensive crisis territory and not a profile that survives in primary care for long.
• The documentation that moves higher ratings tends to involve a home BP log spanning months, end-organ damage evidence, and medication failure across multiple regimens.

The Rating Schedule, Word for Word

38 CFR § 4.104, Diagnostic Code 7101 (Hypertensive vascular disease, hypertension, and isolated systolic hypertension) reads:

60 percent: Diastolic pressure predominantly 130 or more.

40 percent: Diastolic pressure predominantly 120 or more.

20 percent: Diastolic pressure predominantly 110 or more, or; systolic pressure predominantly 200 or more.

10 percent: Diastolic pressure predominantly 100 or more, or; systolic pressure predominantly 160 or more, or; minimum evaluation for an individual with a history of diastolic pressure predominantly 100 or more who requires continuous medication for control.

That's the entire rating table. Four tiers, governed by diastolic readings primarily, with systolic and treatment history as supporting criteria at the 10 and 20 percent levels.

The thing that catches most people: the schedule is built around diastolic pressures that have become uncommon in modern primary care. A patient with diastolic readings in the 120 to 130 range today usually gets pulled into urgent treatment quickly, with multiple medications and close follow-up. The trajectory toward sustained 130-plus diastolics is short, and the people on it are not generally sitting at home waiting for a C&P exam.

So the 40 and 60 percent tiers exist on paper but almost never show up in the actual rating data I've looked at.

The Diagnostic Predicate Most Claims Get Wrong

The note attached to DC 7101 spells out something important:

"Hypertension or isolated systolic hypertension must be confirmed by readings taken two or more times on at least three different days."

This isn't a documentation suggestion. It's the evidentiary threshold for the condition to be rated at all. The file has to show a pattern of elevated readings across at least three separate measurement days, with at least two readings per day. A single high reading at one appointment doesn't satisfy the schedule. Two readings at the same visit don't satisfy it. Even two visits with elevated readings don't satisfy it.

I've seen rating decisions where the causation evidence was solid, the in-service event was documented, and the claim still got denied because the elevated readings were on two visits instead of three. The rater isn't editorializing. The schedule requires what it requires.

This matters more than it should because hypertension is the kind of condition that gets recorded incidentally. A veteran shows up for a knee injury, gets a blood pressure check, the number is high, the provider notes it and moves on. The next reading happens months later at another incidental visit. By the time the claim gets filed, the record might have four or five elevated readings spread across two years, none of which were taken in a "two or more times on this day" pattern.

The cases that clear the diagnostic predicate without trouble are the ones where a primary care provider was actively monitoring blood pressure and ordering serial checks. Cases that depend on incidental readings often fail at the threshold even when everything else is in order.

The "Treated to Lower" Rule: Why 10 Percent Sticks

The 10 percent rating has a clause that does a lot of work in real cases. Read it again:

"Minimum evaluation for an individual with a history of diastolic pressure predominantly 100 or more who requires continuous medication for control."

This is the clause that catches most veterans who are currently on medication with controlled blood pressure.

Here's the pattern. A veteran develops hypertension. Diastolic readings climb into the 100 to 110 range. A provider prescribes lisinopril, or losartan, or HCTZ, or some combination. The medication works. Diastolic drops back into the 80s. The veteran files a claim.

At the C&P exam, the readings come back at, say, 130 over 84. The examiner notes the controlled blood pressure on medication. The rater grants service connection and applies the 10 percent rating under the treated-to-lower clause, because the history shows pre-medication diastolics at or above 100.

The rating doesn't move higher because the current readings are controlled. The history qualifies for the 10 percent floor, but nothing in the post-medication record supports a higher tier. The veteran sits at 10 percent indefinitely.

This is the rating mechanic that catches a lot of filers off guard. A veteran whose pre-treatment readings would have qualified for 20 or 40 percent before medication can end up at 10 percent because the rating tiers above 10 percent are scored on current readings, not historical ones. The treated-to-lower clause secures the floor, but it doesn't preserve the higher tier the pre-treatment readings would have supported.

The result is that effective treatment paradoxically pushes the rating down. The healthier you get on medication, the harder it is to justify a higher rating.

The Oct 2024 Agent Orange Addition

In October 2024, hypertension was added to the list of presumptive conditions for Agent Orange exposure under 38 CFR § 3.309(e). This was authorized by the PACT Act of 2022, which directed VA to add hypertension to the presumptive list following the National Academies of Sciences, Engineering, and Medicine review concluding there was sufficient evidence of an association.

The practical effect: any Vietnam-era veteran with documented Agent Orange exposure who has hypertension can now claim service connection on a presumptive basis, without needing to show a direct nexus to a specific in-service event.

This is the kind of regulatory change that opens up a retroactive supplemental claim path. Veterans who were previously denied hypertension claims, sometimes years or decades ago, now have grounds to file a supplemental claim under 38 CFR § 3.156(c) if the denial happened before Oct 2024 and the Agent Orange exposure was the underlying issue.

The PACT Act includes provisions that, in some cases, can extend the effective date back to the original claim date for conditions added to the presumptive list. The mechanics on this are complicated and depend on when the prior claim was filed, what evidence was available, and how the supplemental is structured.

What I've noticed in the BVA decisions since October is that the new presumptive is showing up in remands more often than in straight grants. The Board is taking the cases that had been pending, recognizing the new presumptive applies, and sending them back to the RO for re-rating. In Claim Raven's analysis of 667 hypertension cases, remands are the single largest outcome bucket at 35.2 percent, edging out grants at 34.2 percent and denials at 30.6 percent. The remand-heavy pattern is consistent with what I'd expect from a recently expanded presumptive framework: cases get sent back so the RO can apply the new rules.

For veterans who were never denied but never filed in the first place, the path is simpler. A new claim citing Agent Orange exposure as the basis for service connection, with documented exposure (Vietnam service typically establishes this), will run through the presumptive framework rather than needing a nexus opinion.

The rating itself still runs through DC 7101. The presumptive only addresses service connection, not the rating tier. So a veteran who establishes service connection through the Agent Orange presumptive still has to clear the diagnostic predicate and still gets the rating from the same schedule that lands most people at 10 percent.

Direct, Secondary, and the Three Service Connection Paths

For veterans without Agent Orange exposure, there are two main paths to service connection for hypertension: direct and secondary.

Direct service connection

Direct service connection requires showing the hypertension began in service or is otherwise directly related to a service event. The cleanest direct claims are the ones where elevated blood pressure was documented during active duty, either at separation physicals or in routine medicals. A veteran with diastolic readings of 95 to 105 in service medical records who developed sustained hypertension after separation has a credible direct theory.

The harder direct claims are the ones where the in-service readings were within normal limits and the hypertension developed later. Those tend to require a medical opinion connecting in-service events (sustained stress exposure, certain medications, environmental exposures) to the later development of hypertension.

Secondary service connection

Secondary service connection is the path most current-era veterans use. Under 38 CFR § 3.310, hypertension can be granted as secondary to a service-connected condition that either caused or aggravated it. The most-filed secondary chains for hypertension are:

• Hypertension secondary to PTSD, which has solid cardiovascular research behind it.
• Hypertension secondary to obstructive sleep apnea. Untreated OSA is one of the most well-established secondary causes of hypertension in the general medical literature.
• Hypertension secondary to diabetes. The renal and vascular effects of diabetes drive blood pressure up through multiple mechanisms.

Presumptive service connection

Presumptive service connection is the path I covered above for Agent Orange. There's no other presumptive pathway for hypertension at the moment. PACT Act burn pit presumptives don't include hypertension. Gulf War presumptives don't include it either.

So for most modern-era veterans, the practical question is whether the hypertension chains off PTSD, sleep apnea, or diabetes. Direct service connection is available but usually requires in-service blood pressure documentation that isn't there.

Why Almost Every Granted Case Lands at 10 Percent

Once service connection is established, the rating tier becomes the next question. And the data here is consistent: the granted cases cluster heavily at 10 percent. Across 667 hypertension cases in this dataset, grants run at 34.2 percent overall, and the nexus-quality breakdown shows what drives them: strong nexus opinions get granted at 98.6 percent across 69 cases, adequate nexus at 82.0 percent across 122 cases, and weak nexus collapses to 9.5 percent across 201 cases. The schedule does the rest of the work after the nexus question is settled.

The reason is the rating schedule itself. The 20 percent threshold requires diastolic pressure predominantly 110 or more, or systolic pressure predominantly 200 or more. In modern medicine, a patient with diastolic readings consistently at 110-plus is on active treatment within weeks of the first reading. Multiple medications get tried. The diastolic gets pulled back below 100. The 20 percent threshold is therefore unstable for most patients. They might cross it briefly during a period of uncontrolled hypertension, but by the time the C&P exam happens, treatment has dropped them back into the 10 percent territory or lower.

The 40 percent threshold is diastolic predominantly 120 or more. Same dynamic, more severe. A patient with sustained diastolics at 120 is generally being managed aggressively, often with three or more medications, sometimes hospitalized for hypertensive urgency. The clinical course usually doesn't allow the rating to sit at 40 percent for long.

The 60 percent threshold is diastolic predominantly 130 or more. This is hypertensive crisis territory. End-organ damage is typically present or developing. Patients in this range are often hospitalized or under specialist care. The rating exists on paper, but the path through it is short either toward emergency intervention or toward end-organ failure.

So the schedule is built for a clinical reality that modern treatment has mostly displaced. The 10 percent tier captures the bulk of veterans who have hypertension, get diagnosed, and start medication that controls it. The higher tiers are reserved for the small subset whose disease isn't controlled by medication or who present in acute crisis.

The cliff isn't gradual. It's not 10 percent for mild, 20 percent for moderate, 40 percent for severe. The schedule jumps in big increments because the underlying clinical thresholds are big increments. There's no continuous gradient from controlled hypertension to crisis.

What Higher Ratings Look Like When They Happen

The 20, 40, and 60 percent ratings do show up. They're rare. The cases I've seen tend to share a few characteristics.

Resistant hypertension on multiple medications. A veteran on three or more antihypertensive medications, including a diuretic, with diastolics still above the tier threshold despite combination therapy. This profile sometimes appears in patients with renal involvement, severe metabolic syndrome, or sleep apnea that hasn't been adequately treated.

Documented end-organ damage. Left ventricular hypertrophy on echocardiogram, hypertensive retinopathy on fundoscopic exam, chronic kidney disease with elevated creatinine and reduced GFR. End-organ damage shifts the rating analysis because it documents that the hypertension has been clinically severe over time, even if current readings are partially controlled.

Hospitalization history for hypertensive emergency. Records showing ER visits or admissions for hypertensive urgency or crisis, with diastolics at or above 120 to 130 at presentation. These don't change the rating directly, but they document a level of severity that the C&P exam might not capture.

Home BP logs over months. Some veterans keep detailed home blood pressure logs that show patterns the in-office readings don't. A log showing diastolic averages above 110 across 90 days of twice-daily readings is harder to dismiss than two elevated readings at a single appointment.

The 20 percent ratings I've seen often involve a veteran whose hypertension hasn't responded well to first-line treatment, with a home log or follow-up readings supporting sustained diastolics at 110 or above. The 40 percent ratings often involve resistant hypertension with end-organ damage. The 60 percent ratings are rare enough that I don't have a clean composite picture. I'm not going to tell anyone what to put in their claim file, that's not my role. The pattern in the data is what it is. The 10 percent ceiling holds for most veterans because the higher tiers require a clinical course that effective treatment usually disrupts.

Supplemental Claims and the Retroactive Window

The Oct 2024 Agent Orange addition creates a specific opportunity for veterans who were previously denied. Under 38 CFR § 3.156(c), when VA receives relevant service records that were not in the file at the time of a prior decision, the supplemental claim can sometimes reach back to the original effective date.

For the Agent Orange presumptive addition, the relevant change isn't service records. It's the regulatory addition itself. The rules around retroactive effective dates for presumptive additions are governed by separate provisions, and the analysis depends on when the prior claim was filed and what the basis of denial was.

The Nehmer provisions, which govern Agent Orange-related claims, can sometimes extend effective dates back to the original claim. Nehmer applies specifically to Vietnam-era veterans who filed claims for conditions later added to the presumptive list. The analysis is fact-specific and depends on the timing of the prior claim relative to the regulatory addition.

For veterans denied hypertension claims tied to Agent Orange exposure before Oct 2024, the supplemental claim window is open. Whether the effective date reaches back to the original denial or starts from the supplemental claim date depends on the Nehmer analysis and the specific facts.

What I'd flag is that the supplemental claim path is one of the few areas where a procedurally clean filing can recover years of back pay. The veterans who filed and were denied in 2018 or 2020 are sometimes the ones with the most to gain from the Oct 2024 change, even though they didn't have the presumptive available at the time.

Bottom Line

Hypertension is rated under 38 CFR § 4.104 DC 7101 at four tiers, 10 through 60 percent, but the granted cases cluster hard at 10 percent because the higher tiers require diastolic readings that modern treatment usually disrupts. The 10 percent tier carries a "treated to lower" clause that secures the floor for veterans on medication with a history of diastolic pressures at or above 100, but it doesn't preserve the higher tier the pre-treatment readings would have qualified for. The Oct 2024 addition of hypertension to the Agent Orange presumptive list under 38 CFR § 3.309(e) opened a retroactive supplemental claim path for Vietnam-era veterans previously denied. The cases that move above 10 percent tend to involve resistant hypertension on multiple medications, documented end-organ damage, and a sustained pattern of elevated readings across months rather than scattered high values. The diagnostic predicate (two readings on three different days) is a binary threshold some claims fail at the rating stage even when causation is otherwise strong. For most veterans with hypertension, the rating ceiling is 10 percent in practice, regardless of how much the condition affects daily life.

Methodology and Limitations

• Data source: Rating criteria quoted directly from 38 CFR § 4.104 Diagnostic Code 7101. Presumptive framework cited from 38 CFR § 3.309(e) as amended in October 2024 under PACT Act authority. Secondary service connection framework cited from 38 CFR § 3.310. Effective date analysis references 38 CFR § 3.156(c) and the Nehmer line of cases. BVA outcome and nexus-quality patterns come from Claim Raven's analysis of 667 hypertension cases pulled from the case_analysis table.
• Sample size: 667 hypertension cases at the BVA level (228 granted, 204 denied, 235 remanded), drawn from a broader corpus of 101,518 condition records drawn from 49,876 Board decisions.
• Classification approach: Rating tier definitions are drawn from the regulatory text. Service connection pathway descriptions reflect typical patterns in BVA decisions involving hypertension claims. Documentation pattern descriptions reflect observed characteristics of cases that moved above the 10 percent floor.
• Limitations:
• These are patterns from cases that made it to the BVA. They don't represent all hypertension claims. RO-level grants and unappealed denials aren't in this dataset.
• The diagnostic predicate ("two or more times on at least three different days") is binary, but how raters interpret what counts as "predominantly" for ratings above 10 percent has some subjectivity.
• The Agent Orange presumptive addition is recent. The BVA decision patterns since October 2024 are still developing.
• The Nehmer effective date analysis for retroactive claims is fact-specific and case-by-case. General descriptions in this post don't substitute for case-specific analysis.
• Pre-treatment versus post-treatment readings affect the rating analysis in ways that aren't always cleanly captured in the medical record.
• The cases that move above 10 percent are rare enough that the composite picture is built on smaller samples than the 10 percent tier descriptions.
• Individual medical situations vary, and these patterns reflect what shows up at the Board, not what happens in any individual claim.